EcoDrugPlus

Renin

Ensembl ID : ENSBMUG00000017726
Gene Symbol: REN
3 Cross references
220 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSBMUG00000012880
Gene Symbol: RET
3 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Alpha

Ensembl ID : ENSBMUG00000003995
Gene Symbol: RARA
3 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSBMUG00000002035
Gene Symbol: RARB
1 Cross references
451 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSBMUG00000022368
Gene Symbol: RARG
3 Cross references
451 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSBMUG00000000903
Gene Symbol: RXRA
3 Cross references
249 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSBMUG00000008461
Gene Symbol: RXRB
3 Cross references
215 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSBMUG00000016035
Gene Symbol: RXRG
3 Cross references
277 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSBMUG00000002376
Gene Symbol: RPL10A
3 Cross references
208 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSBMUG00000011622
Gene Symbol: RPL12
3 Cross references
183 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSBMUG00000012686
Gene Symbol: RPL13
3 Cross references
230 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSBMUG00000016083
Gene Symbol: RPL14
3 Cross references
277 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).